Advances in predictive biomarkers for immuno-oncology agents

Newer treatments for hematological malignancies, including immunotherapies and cellular therapies, are more targeted than historical chemotherapies. This means that the presence of the specific target... Author: VJHemOnc Added: 07/24/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts